2024

  • Nießen, A., Klaiber, U., Lewosinska, M., Nickel, F., Billmann, F., Hinz, U., Büchler,M.W., and Hackert, T., Portal vein resection in pancreatic neuroendocrine neoplasms.Surgery, 2024. (IF 3.8)

  • Nickel F, Wise PA, Müller PC, Kuemmerli C, Cizmic A, Salg GA, Steinle V, Niessen A, Mayer P, Mehrabi A, Loos M, Müller-Stich BP, Kulu Y, Büchler MW, Hackert T. Short-term Outcomes of Robotic Versus Open Pancreatoduodenectomy: Propensity Score-matched Analysis. Ann Surg. 2024 Apr 1;279(4):665-670. doi: 10.1097/SLA.0000000000005981. Epub 2023 Jul 3. PMID: 37389886.

2023

  • Amin T, Viol F, Krause J, Fahl M, Eggers C, Awwad F, Schmidt B, Benten D, Ungefroren H, Fraune C, Clauditz TS, Sauter G, Izbicki JR, Lohse AW, Huber S, Schrader J. Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation. Neuroendocrinology. 2023;113(5):501-518. doi: 10.1159/000528539. Epub 2022 Dec 6. PMID: 36473454. (IF 4.27)

  • Schmidt BC, Leiderer MT, Amin T, Viol F, Huber S, Henes FO, Schrader J. Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors? Endocrine. 2023 Sep 28. doi: 10.1007/s12020-023-03545-x. Epub ahead of print. PMID: 37770647. (IF 3.88)

  • Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, Sundin A, Falconi M, O'Toole D. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J Neuroendocrinol. 2023 Aug;35(8):e13306. doi: 10.1111/jne.13306. Epub 2023 Jul 4. PMID: 37401795. (IF 4.27)

  • Ritter AS, Dumm N, Deisenhofer JM, Franz C, Al-Saeedi M, Büchler MW, Schneider M. Risk Factors for Rectal Stump Leakage After Discontinuity Resection: Stump Length Matters Most. Dis Colon Rectum. 2024 Jan 1;67(1):138-150. doi: 10.1097/DCR.0000000000002929. Epub 2023 Oct 4. PMID: 37792564.

  • Nießen, A., Loos, M., Neumüller, K., Feißt, M., Klaiber, U., Cizmic, A., Al-Saeedi, M.,Roth, S., Schneider, M., Büchler, M.W., and Hackert, T., Impact of circumferentialresection margin on survival in ampullary cancer: retrospective analysis. BJS Open,2023. 7(6). (IF 3.2)

  • Bellotti, R., Paiella, S., Primavesi, F., Jäger, C., Demir, I.E., Casciani, F., Kornprat, P.,Wagner, D., Rösch, C.S., Butturini, G., Giardino, A., Goretzky, P.E., Mogl, M.,Fahlbusch, T., Kaiser, J., Strobel, O., Nießen, A., Luu, A.M., Salvia, R., and Maglione,M., Treatment characteristics and outcomes of pure Acinar cell carcinoma of thepancreas – A multicentric European study on radically resected patients. HPB, 2023. (IF 2.9)


  • Fischer, A., Schoffski, O., Niessen, A., Hamm, A., Langan, E.A., Buchler, M.W., andBillmann, F., Retroperitoneoscopic adrenalectomy may be superior to laparoscopictransperitoneal adrenalectomy in terms of costs and profit: a retrospective pairmatchedcohort analysis. Surg Endosc, 2023. 37(10): p. 8104-8115. (IF 3.1)

  • Nießen, A., Wolfgang, C.L., Hackert, T., and Büchler, M.W., Management ofRecurrence of Cystic Neoplasms, in The Pancreas. 2023. p. 737-743.

  • Hackert, T., Nießen, A., and Büchler, M.W., Extended Radical Surgery for PancreaticCancer, in The Pancreas. 2023. p. 1099-1107.

2022

  • Awwad F, Ozga AK, Amin T, Schlueter C, Kailani S, Perez D, Wolter S, Sauter G, Izbicki J, Lohse AW, Schrader J. Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2022;112(12):1225-1236. doi: 10.1159/000524366. Epub 2022 Mar 30. PMID: 35354139. (IF 4.27)

  • Viol F, Sipos B, Fahl M, Clauditz TS, Amin T, Kriegs M, Nieser M, Izbicki JR, Huber S, Lohse AW, Schrader J. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy. Cell Oncol (Dordr). 2022 Dec;45(6):1401-1419. doi: 10.1007/s13402-022-00727-z. Epub 2022 Oct 21. PMID: 36269546; PMCID: PMC9747820. (IF 6.31)

  • Krug S, Khosravian M, Weissbach J, George K, Damm M, Garbe J, Walldorf J, Reuken PA, Amin T, Siebenhüner A, Rosendahl J, Gress TM, Michl P, Schrader J, Rinke A. The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers (Basel). 2022 Jan 26;14(3):613. doi: 10.3390/cancers14030613. PMID: 35158882; PMCID: PMC8833713. (IF 6.7)

  • Ungefroren H, Künstner A, Busch H, Franzenburg S, Luley K, Viol F, Schrader J, Konukiewitz B, Wellner UF, Meyhöfer SM, Keck T, Marquardt JU, Lehnert H. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling. Int J Mol Sci. 2022 Dec 14;23(24):15868. doi: 10.3390/ijms232415868. PMID: 36555512; PMCID: PMC9781720. (IF 5.6)

  • Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas. Endocr Pathol. 2020 Jun;31(2):182-189. doi: 10.1007/s12022-020-09612-7. PMID: 32144630; PMCID: PMC7250944. (IF 4.23)

  • Nießen A, Schimmack S, Lewosinska M, Hinz U, Bechtiger FA, Hackert T, Büchler MW, Strobel O. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms. Surgery. 2022 Dec;172(6):1791-1799. doi: 10.1016/j.surg.2022.08.020. Epub 2022 Sep 28. PMID: 36180252. (IF 4.3)

  • Nießen A, Schimmack S, Billmann F, Hackert T. Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the Art [Surgery of pancreatic neuroendocrine neoplasms: state of the art]. Chirurgie (Heidelb). 2022 Aug;93(8):745-750. German. doi: 10.1007/s00104-022-01641-8. Epub 2022 May 2. PMID: 35499762. (IF 0.9)

  • Billmann F, Nießen A, Hackert T. Stellenwert der Chirurgie bei fernmetastasierten neuroendokrinen Neoplasien des Pankreas [Importance of surgery in distant metastatic pancreatic neuroendocrine neoplasms]. Chirurgie (Heidelb). 2022 Aug;93(8):758-764. German. doi: 10.1007/s00104-022-01630-x. Epub 2022 Apr 11. PMID: 35403909. (IF 0.9)

  • Nießen A, Bechtiger FA, Hinz U, Lewosinska M, Billmann F, Hackert T, Büchler MW, Schimmack S. Enucleation Is a Feasible Procedure for Well-Differentiated pNEN-A Matched Pair Analysis. Cancers (Basel). 2022 May 23;14(10):2570. doi:10.3390/cancers14102570. PMID: 35626174; PMCID: PMC9139922. (IF 6.5)

  • He L, Boulant S, Stanifer M, Guo C, Nießen A, Chen M, Felix K, Bergmann F, Strobel O, Schimmack S. The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms. Cancer Sci. 2022 May;113(5):1575-1586. doi: 10.1111/cas.15301. Epub 2022 Mar 8. PMID: 35179814; PMCID: PMC9128182. (IF 6.7)